Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Paul Bibeau, VP Business Development, Acquires 100,000 Shares
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Re: Paul Bibeau, VP Business Development, Acquires 100,000 Shares..I'd like to

posted on Feb 01, 2009 08:57AM

see much much more insider buying activities at such a low share price level.

S402005

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply